[Use of levamisole for correcting the immunological reactivity disorders in autoimmune cytopenias].
D000293:Adolescent; D000328:Adult; D000380:Agranulocytosis / Q000188:drug therapy*; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001773:Blood Cells / Q000276:immunology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007970:Leukopenia / Q000188:drug therapy*; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*
D001323:Autoantibodies; D007978:Levamisole
Primenenie levamizola dlia korrektsii narusheniĭ immunologicheskoĭ reaktivnosti u bol'nykh autoimmunnymi tsitopeniiami.